Prosecution Insights
Prosecution Insights
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SOROUSH, LAYLA | 1 | 40.2% | +43.6% |
| ROBERTS, LEZAH | 1 | 48.7% | +36.3% |
| ROMANOWSKI, MICHAEL C | 1 | 54.1% | +61.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18598526 | PHARMACEUTICAL COMPOSITIONS OF TOFACITINIB FOR ORAL ADMINISTRATION | SOROUSH, LAYLA | 182d overdue |
| 18543158 | Buffered Lidocaine Injectable Formulations and Methods for Making Same | ROBERTS, LEZAH | 98d overdue |
| 17658068 | ROCURONIUM BROMIDE PREFILLED SYRINGE | ROMANOWSKI, MICHAEL C | 81d overdue |
| Art Unit | Apps |
|---|---|
| 1622 | 1 |
| 1612 | 1 |
| 1782 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18598526 | PHARMACEUTICAL COMPOSITIONS OF TOFACITINIB FOR ORAL ADMINISTRATION | SOROUSH, LAYLA | 1622 | Other | Non-Final OA | 182d overdue | Pending | Mar 07, 2024 |
| 18543158 | Buffered Lidocaine Injectable Formulations and Methods for Making Same | ROBERTS, LEZAH | 1612 | §103 | Non-Final OA | 98d overdue | Pending | Dec 18, 2023 |
| 17658068 | ROCURONIUM BROMIDE PREFILLED SYRINGE | ROMANOWSKI, MICHAEL C | 1782 | §103 | Final Rejection | 81d overdue | Pending | Apr 05, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial